Frank Porreca

Pharmacology

Phone(520) 626-7421
Emailfrankp@email.arizona.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Frank Porreca is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

7 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Active
2 Not started
17 Finished

Cortical opioid dysfunction in chronic pain
Porreca, F.
National Institutes of Health
4/15/16 → 1/31/21
Project: Research project
Stress-induced descending facilitation from amygdala kappa opioid receptors in functional pain
Porreca, F.
Project: Research project
New Modalities for the Treatment of Pain and Drug Abuse
Hruby, V. J., Hruby, V. J., Porreca, F. & Vanderah, T. W.
Project: Research project
Long-Acting Peripherally-Restricted Peptidic Kappa Opioid Receptor Agonists for Pain
Porreca, F.
National Institutes of Health
8/1/16 → 7/31/17
Project: Research project
Brain reward circuits and relief of ongoing pain
Porreca, F.
National Institutes of Health
6/1/13 → 2/28/18
Project: Research project

32512 Citations
97 h-Index
563 Article
36 Review article
13 Chapter
11 Comment/debate
More

Amygdala, neuropeptides, and chronic pain-related affective behaviors
Neugebauer, V., Mazzitelli, M., Cragg, B., Ji, G., Navratilova, E. & Porreca, F., Jun 15 2020, In: Neuropharmacology. 170, 108052.
Research output: Contribution to journal › Review article › peer-review
2 Scopus citations
An Emerging Role for Prolactin in Female-Selective Pain
Chen, Y., Navratilova, E., Dodick, D. W. & Porreca, F., Aug 2020, In: Trends in Neurosciences. 43, 8, p. 635-648 14 p.
Research output: Contribution to journal › Review article › peer-review
1 Scopus citations
A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain
Kopruszinski, C. M., Navratilova, E., Swiokla, J., Dodick, D. W., Chessell, I. P. & Porreca, F., 2020, (Accepted/In press) In: Cephalalgia.
Research output: Contribution to journal › Article › peer-review
A pain-induced tonic hypodopaminergic state augments phasic dopamine release in the nucleus accumbens
Gee, T. A., Weintraub, N. C., Lu, D., Phelps, C. E., Navratilova, E., Heien, M. L. & Porreca, F., Oct 1 2020, In: Pain. 161, 10, p. 2376-2384 9 p.
Research output: Contribution to journal › Article › peer-review
Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine
Kopruszinski, C. M., Thornton, P., Arnold, J., Newton, P., Lowne, D., Navratilova, E., Swiokla, J., Dodick, D. W., Dobson, C., Gurrell, I., Chessell, I. P. & Porreca, F., Dec 2020, In: Cephalalgia. 40, 14, p. 1535-1550 16 p.
Research output: Contribution to journal › Article › peer-review